|Day Low/High||132.20 / 138.36|
|52 Wk Low/High||102.69 / 146.85|
Upgrades Dova Pharmaceuticals upgraded to Outperform from In-line at Evercore ISI Meridian Bancorp upgraded to Overweight from Neutral at Piper Jaffray; price target raised to $20 Landstar System upgraded to Mkt Perform from Underperform at Raymo...
We see signs that tell us not only is this market not expensive, but there are whole sections that might be ridiculously cheap. The recent merger announcements are a prime example.
I think we can all agree that there will be no increase made to the Fed Funds Rate today.
Straying from these names could land you in quicksand as the 4th quarter begins.
Continue to trade Ingersoll-Rand from the long side looking for gains to the $113 area.
Argus Research details 24 stocks likely to be impacted, one way or the other, by trade wars and tariffs.
These companies have been the stars of the quarterly earning show so far.
Let's check out IR's charts and indicators.
This market clearly has no clue what to buy, with strong GDP growth but challenging trade dynamics and the Facebook and Twitter bombs last week.
This options strategy on SBUX offers potential reward with little risk.
Who, out there in the health care sector, is safe?
These stocks remain among the best places to be.
It looks like China is building again.
We ought to open our eyes to what we don't care about, to what's still made here.
Their overseas business has been carrying them.
The industrial giant historically has outperformed the S&P 500 and its business should continue to grow.
A breakout to new highs could start a leg up to the $80-$85 area.
But perhaps the economy is a bit like the Washington gridlock.
I'm interested in seeing how GE uses its $30 billion in deployable cash over the next couple years
A breakout over $70 gives a price target of $87.